| product name |
Lincomycin |
| cas number |
154-21-2 |
| apperance |
white powder |
| Density |
1.29 g/cm3 |
| MF |
C18H35ClN2O6S |
| MW |
442.998 |
English alias: Lincomycin (USAN/INN); Lincomycin; (2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4, 5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide; Lincomycin,(2S-cis)-Isomer; C18H34N2O6S;
Accurate quality: 442.19000
LogP: 0.27380 [1]
Physical and chemical properties
Appearance and traits: white crystalline solid; slightly odor or special odor; bitter taste. This product is soluble in water or methanol, but slightly soluble in ethanol.
Security Information
Customs code: 2941904000
This product is used for the treatment of osteomyelitis, orally suitable for: respiratory tract infections caused by staphylococcus, streptococcus pyogenes, pneumococcus and anaerobic bacteria, skin and soft tissue infections, female reproductive tract and pelvic infections, and abdominal cavity caused by anaerobic bacteria Infection etc. In addition to the above indications, lincomycin injection can still be used for sepsis caused by streptococcus and staphylococcus, bone and joint infections, surgical adjuvant treatment of chronic bone and joint infections, and acute blood-borne bone marrow caused by staphylococci Yan etc. The concentration of lincomycin that penetrates into the cerebrospinal fluid cannot reach an effective level and is not suitable for the treatment of meningitis.
Audited Supplier 
){kind=link}
){kind=link}